RO 317549
Alternative Names: RO 318161Latest Information Update: 14 Nov 2006
At a glance
- Originator Roche
- Class Antihyperlipidaemics; Antirheumatics; Indoles; Maleimides; Small molecules
- Mechanism of Action Protein kinase C inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Atherosclerosis; Cancer; Coronary artery restenosis; Rheumatic disorders
Most Recent Events
- 12 Jul 1999 No-Development-Reported for Asthma in Switzerland (Unknown route)
- 12 Jul 1999 No-Development-Reported for Atherosclerosis in United Kingdom (Unknown route)
- 12 Jul 1999 No-Development-Reported for Coronary artery restenosis in United Kingdom (Unknown route)